
Myriad Genetics MYGN
€ 5.40
-2.08%
Quartalsbericht 2025-Q3
hinzugefügt 04.11.2025
Myriad Genetics P/CF 2011-2025 | MYGN
P/CF Jährlich Myriad Genetics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -112 | -16.2 | -16.4 | 119 | -20.2 | 23.9 | 27.6 | 16.1 | 13.4 | 20.6 | 15.8 | 15 | 16.6 | 15.3 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 119 | -112 | 8.46 |
P/CF anderer Aktien in der Diagnostik & Forschung
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
26.1 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
1.15 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.826 | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
271 | $ 18.65 | -3.72 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-40.2 | $ 20.72 | -3.9 % | $ 223 M | ||
|
Co-Diagnostics
CODX
|
-1.58 | $ 0.22 | -4.64 % | $ 6.46 M | ||
|
Biocept
BIOC
|
-0.447 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-0.991 | - | 0.22 % | $ 16.8 M | ||
|
Castle Biosciences
CSTL
|
10.9 | $ 39.14 | -0.65 % | $ 1.09 B | ||
|
Danaher Corporation
DHR
|
22.7 | $ 230.35 | - | $ 168 B | ||
|
DarioHealth Corp.
DRIO
|
-1.43 | $ 10.65 | 6.03 % | $ 302 M | ||
|
BioNano Genomics
BNGO
|
-0.0515 | $ 1.5 | -1.45 % | $ 1.91 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-47.7 | - | - | $ 562 M | ||
|
Exact Sciences Corporation
EXAS
|
44.3 | $ 101.58 | - | $ 18.8 B | ||
|
DexCom
DXCM
|
65.2 | $ 67.97 | 0.59 % | $ 26.2 B | ||
|
Enzo Biochem
ENZ
|
-0.00219 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
22.2 | $ 26.61 | -0.41 % | $ 805 M | ||
|
Global Cord Blood Corporation
CO
|
0.396 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-17.1 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-1.63 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.94 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-0.551 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
21.8 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-28.3 | $ 19.07 | -2.1 % | $ 1.03 B | ||
|
Celcuity
CELC
|
-4.78 | $ 101.72 | -0.52 % | $ 4.01 B | ||
|
Heska Corporation
HSKA
|
-38.7 | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
-0.00965 | $ 3.16 | -1.25 % | $ 101 K | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.162 | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
13.1 | $ 226.1 | -0.36 % | $ 41 B | ||
|
Guardant Health
GH
|
-24.4 | $ 102.18 | -0.78 % | $ 12.5 B | ||
|
ENDRA Life Sciences
NDRA
|
-0.297 | $ 4.84 | -4.69 % | $ 2.6 M | ||
|
Neogen Corporation
NEOG
|
17.5 | $ 7.22 | 1.19 % | $ 1.57 B | ||
|
Aspira Women's Health
AWH
|
-1.41 | - | -6.19 % | $ 10.5 M | ||
|
National Research Corporation
NRC
|
26.5 | $ 18.59 | -0.38 % | $ 456 M | ||
|
Koninklijke Philips N.V.
PHG
|
26.5 | $ 27.27 | 0.59 % | $ 20 B | ||
|
Personalis
PSNL
|
-5.62 | $ 8.15 | 0.12 % | $ 483 M | ||
|
Quidel Corporation
QDEL
|
18.7 | $ 29.14 | -0.55 % | $ 1.23 B | ||
|
Illumina
ILMN
|
19.6 | $ 134.01 | -0.7 % | $ 21.3 B | ||
|
Charles River Laboratories International
CRL
|
11.6 | $ 203.03 | -0.26 % | $ 10.4 B | ||
|
RadNet
RDNT
|
15.8 | $ 73.16 | 0.01 % | $ 5.34 B | ||
|
Soleno Therapeutics
SLNO
|
-28.3 | $ 47.85 | 0.42 % | $ 1.92 B | ||
|
Quest Diagnostics Incorporated
DGX
|
14.3 | $ 175.51 | -0.26 % | $ 19.5 B | ||
|
Biodesix
BDSX
|
-1.89 | $ 6.6 | -3.19 % | $ 856 M | ||
|
Motus GI Holdings
MOTS
|
-0.0884 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
13.3 | $ 253.06 | -0.33 % | $ 21.2 B | ||
|
ICON Public Limited Company
ICLR
|
12.9 | $ 182.53 | -0.17 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
40.5 | $ 683.64 | -0.7 % | $ 56.4 B | ||
|
Lantheus Holdings
LNTH
|
11.9 | $ 67.05 | 0.51 % | $ 4.64 B | ||
|
Mettler-Toledo International
MTD
|
30.9 | $ 1 411.78 | -0.59 % | $ 30 B |